The Process Of Our Circulating Tumor Cells Test

What is the process of our cancer testing for early detection?

CancerCTC.com screening technology uses next-generation methods to detect circulating tumor cells (CTCs) in the blood, enabling early cancer detection. CTCs are precursors to circulating tumor DNA (ctDNA) biomarkers, allowing for the earliest possible identification of cancer. With early detection, we are hoping to help people live a better and longer life

What we need to get started

    1. Requisition form from filled out by provider.
    2. Questionnaire form filled out.
    3. Blood samples drawn and ready to ship out.
    4. Make Payment – Providers $700, non providers $850.
    5. Make Payment – Patients can also do this themselves at $950.

How the Blood Test Works: A Step-by-Step Process

1. Draw blood
2. Capture abnormal cells
3. Identify Cancer Cells
4. Output a report

The journey of early cancer detection at CancerCTC.com begins with a straightforward blood draw from the patient.

This initial step ensures minimal discomfort and is completed swiftly, allowing healthcare professionals tocollect a sample that holds critical information about the patient’s health.

Once the blood sample is obtained, it undergoes a meticulous process aimed at capturing abnormal cells. Sophisticated techniques are employed to isolate circulating tumor cells (CTCs) from the vast array of normal cells present in the blood. These CTCs, often shed by tumors into the bloodstream,
serve as vital indicators of cancer presence.

Following the capture of abnormal cells, the next critical phase involves the identification of cancer cells among the isolated CTCs. CancerCTC.com utilizes advanced technologies and methodologies, including immunocytochemistry and molecular profiling, to distinguish cancerous cells from benign ones. These cutting-edge techniques are pivotal in ensuring the accuracy and reliability of the test results.

Upon the successful identification of cancer cells, a comprehensive report is generated for the client. This report details the presence and type of cancer cells detected, providing crucial insights into the patient’s health status. The report is meticulously crafted to be clear and informative, empowering
patients and healthcare providers to make well-informed decisions regarding further diagnostic evaluations and potential treatments.